Related Experiment Video
Updated: Mar 2, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Antiviral drug resistance and hepatitis B: a continuing public health problem
1Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Abstract:
The use of selective antiviral therapy has been very successful in controlling HBV replication in individuals, leading to a reduction in disease progression and mortality. However, the use of first-generation therapies, often the only available option in low-resource settings, can result in a high prevalence of drug resistance mutations. Variants selected by antiviral therapies targeting the viral polymerase can also result in variants in the viral envelope. These variants can allow the virus to escape the host immune response. The effect of antiviral selection pressure on viral variants that may contribute to immune escape requires further investigation.
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Viral Mutations
Development of Antibiotic Resistance
Treatment Resistant Cancers
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

